搜索临床试验以:Rituximab, Fludarabine, Cyclophosphamide, Thymic irradiation and Thymoglobulin
总计2199个结果
-
University of Birmingham主动,不招人
-
National Cancer Institute (NCI)终止
-
Han weidong招聘中复发难治性 B 细胞非霍奇金淋巴瘤 | Decitabine 引发的串联 CD19/CD20 CAR T 细胞中国
-
National Cancer Institute (NCI)完全的
-
German CLL Study GroupMundipharma Pte Ltd.; Roche Pharma AG完全的
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)完全的
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG Oncology主动,不招人
-
University of Alabama at BirminghamNational Cancer Institute (NCI)终止
-
Shanghai General Hospital, Shanghai Jiao Tong University...招聘中
-
American Scitech InternationalBristol-Myers Squibb; Eli Lilly and Company撤销
-
M.D. Anderson Cancer Center完全的
-
Cancer and Leukemia Group BNational Cancer Institute (NCI)完全的
-
Fujian Medical University未知骨髓增生异常综合征 | 白血病,骨髓,急性 | 前体细胞淋巴细胞白血病-淋巴瘤中国
-
Sidney Kimmel Comprehensive Cancer Center at Johns...完全的
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Maryland Stem Cell Research Fund终止
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)完全的
-
Cancer Research UK未知
-
National Cancer Institute (NCI)完全的
-
Institute of Hematology & Blood Diseases HospitalHangzhou Qihan Biotech Co.,Ltd.招聘中
-
University of UlmCentre Hospitalier de Lens (Co-Sponsor)完全的
-
Corregene Biotechnology Co., Ltd招聘中
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)完全的
-
Patrick C. Johnson, MDAstraZeneca招聘中难治性 B 细胞非霍奇金淋巴瘤 | 弥漫性大 B 细胞淋巴瘤 (DLBCL) | 3b 级滤泡性淋巴瘤 | 难治性侵袭性 B 细胞淋巴瘤 | 侵袭性 B 细胞 NHL | 从头或转化的惰性 B 细胞淋巴瘤 | DLBCL,Nos 遗传亚型 | 富含 T 细胞/组织细胞的大 B 细胞淋巴瘤 | EBV 阳性 DLBCL,编号 | 原发性纵隔 [胸腺] 大 B 细胞淋巴瘤 (PMBCL) | 高级 B 细胞淋巴瘤,编号 | C-MYC/BCL6 双重打击高级别 B 细胞淋巴瘤 | C-MYC/BCL2 双重打击高级别 B 细胞淋巴瘤美国
-
Vastra Gotaland Region招聘中干细胞移植 | 缓解期急性髓性白血病 (AML)比利时, 丹麦, 芬兰, 香港, 以色列, 立陶宛, 荷兰, 挪威, 西班牙, 瑞典
-
M.D. Anderson Cancer CenterIntrexon Corporation终止
-
German CLL Study GroupGenzyme, a Sanofi Company; University of Cologne完全的
-
Memorial Sloan Kettering Cancer Center招聘中
-
National Heart, Lung, and Blood Institute (NHLBI)GlaxoSmithKline; University of Virginia完全的
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Astex Pharmaceuticals, Inc.完全的
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy, Baylor College...招聘中
-
Zhejiang UniversityHangzhou Qihan Biotech Co.,Ltd.招聘中
-
Memorial Sloan Kettering Cancer Center完全的
-
M.D. Anderson Cancer CenterCelgene Corporation; The Leukemia and Lymphoma Society完全的
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)完全的
-
Dutch Childhood Oncology GroupSt. Jude Children's Research Hospital; International BFM Study Group完全的
-
Georgetown University终止
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Ziopharm Oncology完全的急性淋巴细胞白血病 | 非霍奇金淋巴瘤 | 最小残留病 | 小淋巴细胞淋巴瘤 | 急性双表型白血病 | III期慢性淋巴细胞白血病 | IV 期慢性淋巴细胞白血病 | CD19阳性 | 破坏 5% 或更多的骨髓有核细胞美国
-
University of Rochester完全的
-
Kite, A Gilead Company完全的
-
National Cancer Institute (NCI)招聘中
-
Masonic Cancer Center, University of MinnesotaNational Cancer Institute (NCI); National Institutes of Health (NIH)撤销
-
Masonic Cancer Center, University of Minnesota撤销滤泡性淋巴瘤 | 急性髓性白血病 | 淋巴母细胞淋巴瘤 | 慢性淋巴细胞白血病 | 淋巴浆细胞性淋巴瘤 | 急性淋巴细胞白血病 | 套细胞淋巴瘤 | 血液系统恶性肿瘤 | 小淋巴细胞淋巴瘤 | 伯基特氏淋巴瘤 | 边缘区B细胞淋巴瘤 | 慢性骨髓增生性疾病 | 高级别非霍奇金淋巴瘤 | 急变期慢性粒细胞白血病 | 贫血,难治性,原始细胞过多 | 幼淋巴细胞淋巴瘤 | 大细胞非霍奇金淋巴瘤美国